[Heparin therapy of the hemolytic-uremic syndrome].
D058186:Acute Kidney Injury / Q000188:drug therapy*; D000311:Adrenal Glands / Q000473:pathology; D000743:Anemia, Hemolytic / Q000150:complications / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007678:Kidney Glomerulus / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D012790:Shwartzman Phenomenon; D013921:Thrombocytopenia / Q000188:drug therapy; D014511:Uremia / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D006493:Heparin
Heparintherapie des hämolytisch-urämischen Syndroms.